Benimidazole Derivatives

6.9 References
1. Al–Douh, M. H., Hamid, S. A., & Osman, H. (2010). 1D and 2D NMR studies of 2–(2–(benzyloxy)–3–methoxyphenyl)–1H–benzimidazole. Indonesian Journal of Chemistry, 7(2), 190-196.
2. Yerragunta, V., Patil, P., Srujana, S., Devi, R., Gayathri, R., & Aary, D. (2014). Benzimidazole Derivatives and its Biological Importance: A Review. PharmaTutor, 2(3), 109-113.
3. Siddiqui, N., Alam, M. S., Sahu, M., Yar, M. S., Alam, O., & Siddiqui, M. J. A. (2016). Antidepressant, Analgesic Activity and SAR Studies of Substituted Benzimidazoles. Asian Journal of Pharmaceutical Research, 6(3), 170-174.
4. Güneş, H. S., & Coşar, G. (1992). Synthesis of some hydroxamic acid derivatives of benzimidazole and their antibacterial and antifungal activities.

LaBarbera, D. V., & Skibo, E. B. (2005). Synthesis of imidazo [1, 5, 4-de] quinoxalin-9-ones, benzimidazole analogues of pyrroloiminoquinone marine natural products. Bioorganic & medicinal chemistry, 13(2), 387-395.
11. Rasmussen, T. D., Guerra, B., & Issinger, O. G. (2015). Screening of DTP compound libraries for CK2 inhibitors with focus on natural products. In Protein Kinase CK2 Cellular Function in Normal and Disease States (pp. 319-340). Springer International Publishing.
12. Wang, M., Han, X., & Zhou, Z. (2015). New substituted benzimidazole derivatives: a patent review (2013–2014). Expert opinion on therapeutic patents, 25(5), 595-612.
13. Raghunath, M., & Viswanathan, C. L. (2014). Benzimidazole-2-Carbamic acid as a privileged scaffold for antifungal, anthelmintic and antitumor activity: A review. Int J Pharm Pharm Sci, 6(5), 17-25.
14. Eisa, H. M., Barghash, A. E. M., Badr, S. M. and Farahat, A. A. (2010). Synthesis and antimicrobial activity of certain benzimidazole and fused benzimidazole derivatives. Indian Journal of Chemistry. Section B, Organic including medicinal, 49(11),

Sharma, A., Luxami, V., & Paul, K. (2013). Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids. Bioorganic & medicinal chemistry letters, 23(11), 3288-3294.
24. Munguía, B., Mendina, P., Espinosa, R., Lanz, A., Saldaña, J., J Andina, M., ... & Domínguez, L. (2013). Synthesis and anthelmintic evaluation of novel valerolactam-benzimidazole hybrids. Letters in Drug Design & Discovery, 10(10), 1007-1014.
25. Secci, D., Bolasco, A., D'Ascenzio, M., della Sala, F., Yáñez, M., & Carradori, S. (2012). Conventional and Microwave‐Assisted Synthesis of Benzimidazole Derivatives and Their In Vitro Inhibition of Human Cyclooxygenase. Journal of Heterocyclic Chemistry, 49(5), 1187-1195.
26. Ràfols, C., Bosch, E., Ruiz, R., Box, K. J., Reis, M., Ventura, C., ... & Martins, F. (2011). Acidity and hydrophobicity of several new potential antitubercular drugs: isoniazid and benzimidazole derivatives. Journal of Chemical & Engineering Data, 57(2), 330-338.
27. Schaus, J. M., Thompson, D. C., Bloomquist, W. E., Susemichel, A. D., Calligaro, D. O., & Cohen, M. L. (1998). Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives. Journal of medicinal chemistry, 41(11),